🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators hypothesize that the combination of eribulin and zanzalin...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2025-10-22
Trial ID
NCT06957431
Treatments Being Tested
This research is being done to compare rates of hair loss of people with me...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2021-10-07
Trial ID
NCT04986579
Treatments Being Tested
To determine the maximum tolerated dose of E7389 in patients with advanced ...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00069264
Treatments Being Tested
This phase II trial studies how well atezolizumab, cobimetinib, and eribuli...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-11
Trial ID
NCT03202316
Treatments Being Tested
This study is a real-world study. we collected patients with advanced HER2-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03
Trial ID
NCT07480694
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of Cadonilim...
Status
Not Yet Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2024-02-10
Trial ID
NCT06202313
Treatments Being Tested
This is a prospective, non-randomized, open-label, multicenter, single-arm ...
Status
Completed
Location
Institut Gustave Roussy
Start Date
2012-08
Trial ID
NCT01669252
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
This is a phase 3, multicenter, open-label, randomized active-controlled, p...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2019-05-30
Trial ID
NCT03786094
Treatments Being Tested